Precision BioSciences, Inc.DTILNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+1715.7%
5Y CAGR+565.5%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+1715.7%/yr
Quarterly compound
5Y CAGR
+565.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
13058.2x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 263007.69% |
| Q3 2025 | -27.78% |
| Q2 2025 | -37.93% |
| Q1 2025 | -95.45% |
| Q4 2024 | 10.76% |
| Q3 2024 | -98.85% |
| Q2 2024 | 183.77% |
| Q1 2024 | 149.84% |
| Q4 2023 | -46.36% |
| Q3 2023 | -33.70% |
| Q2 2023 | 125.39% |
| Q1 2023 | -17.15% |
| Q4 2022 | 43.94% |
| Q3 2022 | 92.75% |
| Q2 2022 | 15.16% |
| Q1 2022 | -47.67% |
| Q4 2021 | -73.63% |
| Q3 2021 | -65.07% |
| Q2 2021 | 320.85% |
| Q1 2021 | 84.82% |
| Q4 2020 | 20.14% |
| Q3 2020 | 583.02% |
| Q2 2020 | -84.60% |
| Q1 2020 | 7.30% |
| Q4 2019 | 34.06% |
| Q3 2019 | -9.72% |
| Q2 2019 | -1.34% |
| Q1 2019 | 10.57% |
| Q4 2018 | 94.41% |
| Q3 2018 | 35.59% |
| Q2 2018 | 22.64% |
| Q1 2018 | 0.00% |